Neonc Technologies Holdings (NTHI) Fundamentals 2026 — Revenue Analysis | SniperIQ
Neonc Technologies Holdings (NTHI) is a US-listed Healthcare company in Biotechnology with a market capitalization of $72M, trading at
Neonc Technologies Holdings (NTHI) has a market capitalization of approximately $72M, trading at
Neonc Technologies Holdings runs a net profit margin of 0.0%, a gross margin of 0.0%, and an operating margin of 0.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Neonc Technologies Holdings reported revenue of
Neonc Technologies Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Neonc Technologies Holdings carries a debt-to-equity ratio of -0.03x and a current ratio of 0.08x, with a market beta of 0.29. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Neonc Technologies Holdings (NTHI) the key facts are: market cap $72M, revenue
Get Neonc Technologies Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.